Investing

ReviR Therapeutics secures $30 million for its drug discovery platform. RetiSpec raises $10 million for its eye-diagnostics offering. SoundHealth scores $7 million for its acoustics medical device for nasal congestion.

The company will use the funds to accelerate its growth and build its product offerings.

Scopio Labs secured $42 million in Series D funding, and robotics company NAVIGANTIS closed a $12 million Series A round.

The funding comes less than a year after the virtual mental health company closed a $125 million Series C funding round.

Also, a Hong Kong project has received $5 million in funding to develop LLM-run companion robots for the mentally underserved.

Also, five digital health projects are sharing almost $1 million in funding for their respective pilots.

The company will use the funds to accelerate its growth, expand the use of its models for different conditions and open an office in Cambridge.

Thyme Care secures $60 million in Series B funding, and Neuspera Medical garners $23 million.

If investment patterns in the first half of 2024 persist, this year could exceed year-end totals seen in 2019 and 2023, according to Rock Health's H1 2024 digital health funding report.

Unseen Capital funds entrepreneurs of early-stage healthcare companies focused on addressing the needs of underserved communities.